1,513
Views
4
CrossRef citations to date
0
Altmetric
Articles

Feasibility of palliating recurrent gynecological tumors with MRGHIFU: comparison of symptom, quality-of-life, and imaging response in intra and extra-pelvic disease

, , , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 623-632 | Received 08 Feb 2021, Accepted 11 Mar 2021, Published online: 22 Apr 2021

References

  • Gressel GM, Dioun SM, Richley M, et al. Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer. Gynecol Oncol. 2019;152:509–513.
  • Cordeiro ER, Cathelineau X, Thuroff S, et al. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int. 2012;110:1228–1242.
  • Wu F. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J Gastroenterol. 2014;20:16480–16488.
  • Marinova M, Huxold HC, Henseler J, et al. Clinical effectiveness and potential survival benefit of US-guided high-intensity focused ultrasound therapy in patients with advanced-stage pancreatic cancer. Ultraschall Med. 2019;40:625–637.
  • Sibille A, Prat F, Chapelon JY, et al. Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology. 1993;50:375–379.
  • Jolesz FA, Hynynen K, McDannold N, et al. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am. 2005;13:545–560.
  • Rabkin BA, Zderic V, Crum LA, et al. Biological and physical mechanisms of HIFU-induced hyperecho in ultrasound images. Ultrasound Med Biol. 2006;32:1721–1729.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
  • Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia. 2015;31:302–309.
  • Huisman M, Lam MK, Bartels LW, et al. Feasibility of volumetric MRI-guided high intensity focused ultrasound (MR-HIFU) for painful bone metastases. J Ther Ultrasound. 2014;2:16.
  • Pron G. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser. 2015;15:1–86.
  • Zhang L, Chen WZ, Liu YJ, et al. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2010;73:396–403.
  • O'Sullivan AK, Thompson D, Chu P, et al. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009;25:14–25.
  • Chen J, Li Y, Wang Z, et al., Committee of the Clinical Trial of HIFU versus Surgical Treatment for Fibroids. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125:354–364.
  • Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med. 2009;60:417–430.
  • Groenvold M, Petersen MA, Aaronson NK, et al., EORTC Quality of Life Group. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2006;42:55–64.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736.
  • Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23:129–138.
  • Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imaging. 2008;27:376–390.
  • Giles SL, Winfield JM, Collins DJ, et al. Value of diffusion-weighted imaging for monitoring tissue change during magnetic resonance-guided high-intensity focused ultrasound therapy in bone applications: an ex-vivo study. Eur Radiol Exp. 2018;2:10.
  • Ge HY, Miao LY, Xiong LL, et al. High-intensity focused ultrasound treatment of late-stage pancreatic body carcinoma: optimal tumor depth for safe ablation. Ultrasound Med Biol. 2014;40:947–955.
  • Giles SL, Rivens I, Imseeh G, et al. Magnetic Resonance guided high intensity focused ultrasound for treating recurrent gynaecological tumors: effect of pre-focal tissue characteristics on target heating. J Imaging Interv Radiol. 2020;3:1–10.
  • Jones TA, Chin J, McLeod D, et al. High intensity focused ultrasound for radiorecurrent prostate cancer: a North American Clinical Trial. J Urol. 2018;199:133–139.
  • Pasticier G, Chapet O, Badet L, et al. Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results. Urology. 2008;72:1305–1309.
  • Madersbacher S, Kratzik C, Susani M, et al. Transcutaneous high-intensity focused ultrasound and irradiation: an organ-preserving treatment of cancer in a solitary testis. Eur Urol. 1998;33:195–201.
  • Sofuni A, Moriyasu F, Sano T, et al. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol. 2014;20:9570–9577.
  • Hurwitz MD, Ghanouni P, Kanaev SV, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014;106:dju082.
  • Voogt MJ, Trillaud H, Kim YS, et al. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol. 2012;22:411–417.
  • Yoon SW, Cha SH, Ji YG, et al. Magnetic resonance imaging-guided focused ultrasound surgery for symptomatic uterine fibroids: estimation of treatment efficacy using thermal dose calculations. Eur J Obstet Gynecol Reprod Biol. 2013;169:304–308.
  • McDonald R, Chow E, Rowbottom L, et al. Quality of life after palliative radiotherapy in bone metastases: a literature review. J Bone Oncol. 2015;4:24–31.
  • Dababou S, Marrocchio C, Scipione R, et al. High-intensity focused ultrasound for pain management in patients with cancer. Radiographics. 2018;38:603–623.
  • Harding D, Giles SL, Brown MRD, et al. Evaluation of quality of life outcomes following palliative treatment of bone metastases with magnetic resonance-guided high intensity focused ultrasound: an international multicentre study. Clin Oncol (R Coll Radiol). 2018;30:233–242.
  • Farina E, Macchia G, Siepe G, et al. Palliative short-course radiotherapy in advanced pelvic cancer: a phase II study (SHARON Project). Anticancer Res. 2019;39:4237–4242.
  • Liu Y, Zhang WW, He M, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperthermia. 2018;35:56–61.
  • Yin N, Hu L, Xiao ZB, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperthermia. 2018;34:1298–1303.
  • Gorny KR, Chen S, Hangiandreou NJ, et al. Initial evaluation of acoustic reflectors for the preservation of sensitive abdominal skin areas during MRgFUS treatment. Phys Med Biol. 2009;54:N125–N133.
  • Yoon SW, Seong SJ, Jung SG, et al. Mitigation of abdominal scars during MR-guided focused ultrasound treatment of uterine leiomyomas with the use of an energy-blocking scar patch. J Vasc Interv Radiol. 2011;22:1747–1750.
  • Keserci B, Duc NM. Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects. J Ther Ultrasound. 2017;5:22.
  • Jewell ML, Weiss RA, Baxter RA, et al. Safety and tolerability of high-intensity focused ultrasonography for noninvasive body sculpting: 24-week data from a randomized, sham-controlled study. Aesthet Surg J. 2012;32:868–876.
  • Lee HJ, Lee MH, Lee SG, et al. Evaluation of a novel device, high-intensity focused ultrasound with a contact cooling for subcutaneous fat reduction. Lasers Surg Med. 2016;48:878–886.